Harrilene Apleni

Harrilene Apleni

Auto-generated profile, based on publicly available information

Harrilene Apleni

University of the Witwatersrand

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Wits Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JNJoseline Nkhoma
Joseline Nkhoma
HAHarrilene Apleni
Harrilene Apleni
GLGontse Leballo
Gontse Leballo
PCPalesa Motshabi Chakane
Palesa Motshabi Chakane
MKMoses Mogakolodi Kebalepile
Moses Mogakolodi Kebalepile
Background: Neonatal anaemia is common, particularly in preterm and critically ill infants, and is frequently managed with red blood cell transfusion despite well-recognised associated morbidity. Patient blood management strategies aim to reduce transfusion exposure, and tranexamic acid (TXA) has emerged as a potential pharmacological adjunct. However, evidence supporting the use of TXA in neonates remains limited. Methods: We conducted a comprehensive narrative review of peer-reviewed literature published between January 2015 and December 2025. Searches were performed in PubMed/MEDLINE, Scopus, and Web of Science using Medical Subject Headings and keyword combinations related to neonates, children, blood conservation strategies, and TXA. Eligible studies included systematic reviews, randomised controlled trials, observational cohort studies, and case reports evaluating TXA use in paediatric and neonatal populations across surgical, critical care, and selected medical contexts. Adult-only and animal studies were excluded. Findings were synthesised qualitatively. Results: Seventeen studies met the inclusion criteria. Evidence consistently supports the use of TXA as part of multimodal blood-conservation strategies in elective paediatric surgery with predictable bleeding, particularly in craniosynostosis surgery, where reductions in blood loss and transfusion requirements were observed. In paediatric cardiac surgery and life-threatening haemorrhage, TXA may reduce bleeding and early mortality; however, benefits were less consistent in neonates. Evidence for TXA use in neonatal medical indications was sparse and inconclusive. Safety data suggest a dose- and context-dependent risk of seizures, with limited neonatal-specific adverse event reporting. Conclusion: TXA shows promise as a pharmacological blood conservation strategy in selected paediatric surgical populations, but evidence supporting its routine use in neonates remains limited. The unique haemostatic physiology, immature renal clearance, and neurological vulnerability of neonates necessitate cautious use. High-quality neonatal pharmacokinetic studies and prospective trials are urgently needed to define optimal dosing, safety, and efficacy before widespread adoption in neonatal practice.

6 January 2025 in Journal of the Colleges of Medicine of South Africa
Verified
Journal Article
Open access
PDF file
HAHarrilene Apleni
Harrilene Apleni
JSJuan Scribante
Juan Scribante
HPHelen Perrie
Helen Perrie
ZJZainub Jooma
Zainub Jooma
Background: Anaesthetists are expected to have a basic understanding of diathermy use. The aim of this study is to evaluate anaesthetists’ knowledge and awareness of diathermy use in the Department of Anaesthesiology at the University of the Witwatersrand, Johannesburg, South Africa.Methods: A prospective, descriptive and contextual study was conducted utilising an anonymous self-administered questionnaire distributed to anaesthetists during academic meetings, and convenience sampling was used. A minimum sample size of 96 anaesthetists was estimated. Using the modified Angoff Method, a score of 62% was determined for adequate knowledge.Results: One hundred and one questionnaires met the criteria for analysis. The overall mean score obtained for knowledge was 44.7%; 47.7% for junior anaesthetists versus 42.7% for senior anaesthetists (p = 0.20). The total number of anaesthetists achieving an adequate score was 13 (12.9%). Of those, 10 (76.9%) were junior anaesthetists with a mean score of 71.0%, and 3 (23.1%) were senior anaesthetists with a mean score of 67.0% (p = 0.72). There was no significant difference in the knowledge between anaesthetists with Fellowship of the College of Anaesthesia Part 1 examinations and those without (p = 0.34). In a comparison of knowledge between junior and senior anaesthetists, junior anaesthetists scored significantly better in the category of precautions and appropriate use (p = 0.02).Conclusion: The University of the Witwatersrand (Wits) anaesthetists demonstrated poor overall knowledge of diathermy. While anaesthetists do not apply diathermy pads or use diathermy themselves, they are responsible for patients’ safety in the operating theatre and diathermy may interfere with anaesthetic equipment or patient devices.Contribution: This study investigated anaesthetists’ knowledge and awareness pertaining to diathermy use in the operating theatre. It has highlighted the need for ongoing education pertaining to diathermy safety for anaesthetists.

1 January 2026 in Southern African Journal of Anaesthesia and Analgesia
Verified
Journal Article
Open access
HAHarrilene C. Apleni
Harrilene C. Apleni
MKMoses Mogakolodi Kebalepile
Moses Mogakolodi Kebalepile
PCPalesa Motshabi Chakane
Palesa Motshabi Chakane
Background: Neonates undergoing major non-cardiac surgery are highly susceptible to anaemia, perioperative blood loss and transfusion exposure. Perioperative blood management (PBM) in this population is challenging due to limited physiological reserve and the absence of robust, neonatal-specific evidence to guide practice. Aim: To evaluate the epidemiology of blood transfusion and current evidence on PBM in neonates undergoing major non-cardiac surgery. Method: A state-of-the-art narrative review was conducted across PubMed, Web of Science and Scopus for studies published between January 2015 and December 2025. Eligible studies included primary research involving neonates (≤ 28 days) undergoing major non-cardiac surgery and reporting on transfusion practices, anaemia management, perioperative blood loss or related epidemiologic outcomes. Study selection followed predefined Population, Intervention/Exposure, Comparator and Outcomes criteria. Results: A very limited number of studies met inclusion criteria, with most excluded due to non-neonatal populations, a lack of surgical context or absence of blood management outcomes. Included studies were predominantly observational and demonstrated marked heterogeneity in transfusion practices. Evidence regarding transfusion thresholds, perioperative blood loss and PBM strategies was sparse and inconsistent. No high-quality trials directly evaluating PBM interventions in this population were identified. Conclusion: There is a critical lack of high-quality evidence guiding PBM in neonatal major non-cardiac surgery. Current practices are largely extrapolated from older populations. Well-designed prospective and multicentre studies are urgently needed to establish evidence-based transfusion thresholds and optimise PBM strategies in this vulnerable group. Contribution: This review synthesises evidence on neonatal perioperative blood management, revealing transfusion practice variability, evidence gaps, and the need for neonatal-specific guidelines.